L49.3
Exfoliation due to erythematous condition involving 30-39 percent of body surface
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code L49.3 refers to a condition characterized by skin peeling (exfoliation) caused by an erythematous (red, inflamed) skin condition affecting between 30% and 39% of the body surface. This condition occurs when widespread inflammation leads to the shedding of skin layers, often resulting in discomfort and skin vulnerability.
Causes & Symptoms
Clinical Causes: Severe inflammatory skin disorders such as psoriasis or eczema Drug reactions inducing skin inflammation and peeling Infections that lead to widespread skin erythema and exfoliation Autoimmune conditions targeting the skin Severe sunburn or thermal injury Chemical burns or exposure to irritants Certain systemic illnesses associated with skin involvement
Key Symptoms: Extensive redness and inflammation of the skin Significant skin peeling or shedding across large areas Skin discomfort, including pain, itching, or burning sensation Presence of blisters or raw skin underlying the peeled areas General feeling of malaise or weakness in severe cases Possible fluid loss and dehydration if the skin barrier is severely compromised
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical examination by a healthcare professional, focusing on skin appearance, distribution, and extent. Medical history is reviewed to identify any potential triggers such as medication use or recent illnesses. In some cases, skin biopsy or laboratory tests may be performed to confirm underlying causes or exclude other skin conditions. The extent of affected body surface is assessed to classify the severity of the exfoliation.
Treatment Protocols: Treatment aims to manage symptoms, prevent complications, and address underlying causes. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is L49.3 a billable ICD-10 code?
Yes, L49.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L49.3?
Clinical documentation must specify the nature of Exfoliation due to erythematous condition involving 30-39 percent of body surface and any associated comorbidities for accurate reporting.
Cite this Clinical Reference